Smruthi Organics Limited engages in manufactures and markets active pharmaceutical ingredient (API) products to India, Asia, Africa, the Americas, and Internationally. The company provides API for cardiovascular which includes amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives, including ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine. In addition, it is developing empagliflozin for anti-diabetics; and apixaban and rivaroxaban for anti-platelets. It exports its products. Smruthi Organics Limited was incorporated in 1989 and is headquartered in Solapur, India.